JPH01124396A - リボソ−ムワクチンの工業的製法およびリボソ−ムワクチン - Google Patents

リボソ−ムワクチンの工業的製法およびリボソ−ムワクチン

Info

Publication number
JPH01124396A
JPH01124396A JP62063656A JP6365687A JPH01124396A JP H01124396 A JPH01124396 A JP H01124396A JP 62063656 A JP62063656 A JP 62063656A JP 6365687 A JP6365687 A JP 6365687A JP H01124396 A JPH01124396 A JP H01124396A
Authority
JP
Japan
Prior art keywords
ribosome
pneumoniae
ribosomes
membrane
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62063656A
Other languages
English (en)
Japanese (ja)
Inventor
D Hinterland Lucien Dussourd
ルシエン　デュソー　ダンテルラン
Gerard Normier
ジエラール　ノルミエ
Anne-Marie Pinel
アンヌーマリー　ピネル
Jacques Durand
ジャック　デュラン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of JPH01124396A publication Critical patent/JPH01124396A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
JP62063656A 1986-03-18 1987-03-18 リボソ−ムワクチンの工業的製法およびリボソ−ムワクチン Pending JPH01124396A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8603829A FR2596064B1 (fr) 1986-03-18 1986-03-18 Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
FR8603829 1986-03-18

Publications (1)

Publication Number Publication Date
JPH01124396A true JPH01124396A (ja) 1989-05-17

Family

ID=9333224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62063656A Pending JPH01124396A (ja) 1986-03-18 1987-03-18 リボソ−ムワクチンの工業的製法およびリボソ−ムワクチン

Country Status (8)

Country Link
EP (1) EP0238407B1 (https=)
JP (1) JPH01124396A (https=)
AT (1) ATE79037T1 (https=)
AU (1) AU7009387A (https=)
DE (1) DE3780843T2 (https=)
ES (1) ES2051759T3 (https=)
FR (1) FR2596064B1 (https=)
GR (1) GR3005567T3 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001182685A (ja) * 1999-11-19 2001-07-06 Boc Group Plc:The 改良真空ポンプ
JP2020045298A (ja) * 2018-09-14 2020-03-26 株式会社島津製作所 分析用試料の調製方法、分析方法および微生物の識別方法

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739382B1 (fr) * 1995-09-28 1997-11-14 Oreal Fraction ribosomale et composition la contenant
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen
FR2790959B1 (fr) * 1999-03-15 2003-06-27 Pf Medicament Utilisation de fractions membranaires bacteriennes a effet adjuvant, leurs procedes de preparation et composition pharmaceutique les contenant
FR2790960B1 (fr) * 1999-03-15 2002-10-31 Pf Medicament Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant
FR2790961B1 (fr) * 1999-03-17 2001-06-22 Fabre Pierre Sante Utilisation d'une composition comprenant des proteoglycanes de klebsiella pneumoniae, et des ribosomes ou des arn ribosomaux bacteriens pour le traitement et/ou la prevention des maladies parodontales
GB2370838A (en) 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2253499B1 (https=) * 1973-12-10 1977-11-04 Fabre Sa Pierre
FR2305990A1 (fr) * 1975-04-02 1976-10-29 Fabre Sa Pierre Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens
FR2360314A2 (fr) * 1976-08-06 1978-03-03 Fabre Sa Pierre Nouveaux vaccins perfectionnes a base de fractions ribosomales
FR2444464A1 (fr) * 1978-12-19 1980-07-18 Fabre Sa Pierre Proteoglycanes bacteriens purifies, procede pour leur preparation et vaccin les contenant

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001182685A (ja) * 1999-11-19 2001-07-06 Boc Group Plc:The 改良真空ポンプ
JP2020045298A (ja) * 2018-09-14 2020-03-26 株式会社島津製作所 分析用試料の調製方法、分析方法および微生物の識別方法

Also Published As

Publication number Publication date
GR3005567T3 (https=) 1993-06-07
FR2596064B1 (fr) 1990-02-02
ES2051759T3 (es) 1994-07-01
EP0238407B1 (fr) 1992-08-05
AU7009387A (en) 1987-09-24
DE3780843D1 (de) 1992-09-10
EP0238407A1 (fr) 1987-09-23
ATE79037T1 (de) 1992-08-15
FR2596064A1 (fr) 1987-09-25
DE3780843T2 (de) 1992-12-24

Similar Documents

Publication Publication Date Title
US4271147A (en) Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
JP5688902B2 (ja) 莢膜Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ多糖の生産のための短縮された精製プロセス
RU2181378C2 (ru) Способ высокоуровневой экспрессии, способ очистки и способ переукладки поринового протеина внешней мембраны менингококка группы в или слитого с ним протеина, высокоочищенный пориновый протеин (варианты), высокоочищенный пориновый слитый протеин (варианты), вакцина для предупреждения бактериального менингита группы в, способ получения конъюгата протеина менингококка группы в и полисахарида, способ предупреждения бактериального менингита, штамм е.coli (варианты)
CA1146862A (en) Multivalent pneumococcal vaccine and preparation thereof
US6146902A (en) Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
EP0157899B1 (en) Multivalent pneumococcal vaccine and preparation thereof
JP2006505628A5 (https=)
JP2010521972A5 (https=)
US6797476B2 (en) Process for the scaleable purification of plasmid DNA
JPH01124396A (ja) リボソ−ムワクチンの工業的製法およびリボソ−ムワクチン
JP2878788B2 (ja) グラム陰性多糖類から細菌内毒素を除去するための方法
BR112017023437B1 (pt) Métodos para o isolamento de polissacarídeo capsular de bactérias e composição imunogênica
CN106062006B (zh) 用于纯化多糖的新的下游方法
WO2011148382A1 (en) An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol.
US4123520A (en) Method for preparing high molecular weight meningococcal Group C vaccine
US4349540A (en) Process for preparing vaccines based on antigenic ribosomal fractions
CN106215183A (zh) 一种abc群脑膜炎球菌联合疫苗及其制备方法
JP4856833B2 (ja) プラスミドｄｎａの大規模化可能な精製方法
WO1987006939A1 (en) Process for isolating and purifying p. falciparum cs protein vaccine expressed in recombinant e. coli
HU200194B (en) Process for removal of pertussis endotoxin
US4235994A (en) High molecular weight meningococcal group C vaccine and method for preparation thereof
US5045456A (en) Process for removing bacterial endotoxin from gram-negative polysaccharides
JPS61171432A (ja) 免疫原性蛋白質またはペプチド複合体からなるワクチン
JP2003503041A (ja) 内在性膜タンパク質の抽出
JP2002511490A (ja) モラキセラ（ｍｏｒａｘｅｌｌａ）のトランスフェリン受容体遺伝子